Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
166-180 of 598
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Rewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
FCDC Action CenterRewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
Combination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
FCDC Action CenterCombination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living RheumDelaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
FCDC Action CenterImproving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
- advertisement
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Eye on Ocular HealthImaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Eye on Ocular HealthDefining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Personalizing Treatment for Chronic Ocular Surface Pain
Eye on Ocular HealthPersonalizing Treatment for Chronic Ocular Surface Pain
Improved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Clinician's RoundtableImproved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Eye on Ocular HealthTargeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
DOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
Clinician's RoundtableDOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
- advertisement
First-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
Clinician's RoundtableFirst-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living RheumImproving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
Clinician's RoundtableSaliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential



































